arrow
A

Alexandra Wright-Hughes

University of Leeds
H指数:17
被引数:1,286

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Latent Class Analysis May Predict Patients with Irritable Bowel Syndrome Who Respond to Amitriptyline: Post Hoc Analyses from ATLANTIS

潜变量分析可预测对阿米替林有反应的肠易激综合征患者:ATLANTIS研究的<em>事后</em>分析

2026-11-050
OAAI
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiences
2025-03-012
OAAI
Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial

对低剂量阿米替林治疗肠易激综合征的反应预测因子以及根据亚型的疗效和耐受性:ATLANTIS试验的事后分析

GUT
IF25.8
2025-01-251
PRE
Effectiveness of early vocational rehabilitation versus usual care to support RETurn to work after stroKE: A pragmatic, parallel-arm multicenter, randomized controlled trial
2024-12-311
PRE
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT
2024-10-012
OA
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial
LANCET
IF88.5
2023-11-0141
OAAI
A randomised fractional factorial screening experiment to predict effective features of audit and feedback
2022-05-267
OAAI
Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial

拉帕替尼联合卡培他滨与曲妥珠单抗联合卡培他滨治疗人类表皮生长因子受体2阳性转移性乳腺癌伴中枢神经系统转移的比较 (LANTERN): 一项II期随机试验

2020-10-0111
PREAI
Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: An extended follow up of pragmatic randomised controlled trial

自我伤害后,系统性家庭治疗与常规治疗相比的长期有效性: 实用性随机对照试验的扩展随访

2020-01-0110
OAAI
Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial
2018-03-0169
OAAI